Physicochemical characterization and phase II metabolic profiling of echinochrome A, a bioactive constituent from sea urchin, and its physiologically based pharmacokinetic modeling in rats and humans
Open Access
- 31 March 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 162, 114589
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
This publication has 32 references indexed in Scilit:
- Mechanisms of echinochrome potency in modulating diabetic complications in liverLife Sciences, 2016
- A Whole-Body Physiologically Based Pharmacokinetic Model of Gefitinib in Mice and Scale-Up to HumansThe AAPS Journal, 2015
- Echinochrome A Protects Mitochondrial Function in Cardiomyocytes against Cardiotoxic DrugsMarine Drugs, 2014
- Stability of polyhydroxylated 1,4‐naphthoquinone pigment recovered from spines of sea urchin Strongylocentrotus nudusInternational Journal of Food Science and Technology, 2012
- Extraction and antioxidant property of polyhydroxylated naphthoquinone pigments from spines of purple sea urchin Strongylocentrotus nudusFood Chemistry, 2011
- High-performance liquid chromatography–tandem mass spectrometry in the identification and determination of phase I and phase II drug metabolitesAnalytical and Bioanalytical Chemistry, 2008
- Physiologically based pharmacokinetic modelling 2: Predicting the tissue distribution of acids, very weak bases, neutrals and zwitterionsJournal of Pharmaceutical Sciences, 2006
- Echinamines A and B, First Aminated Hydroxynaphthazarins from the Sea Urchin Scaphechinus mirabilisJournal of Natural Products, 2005
- Mechanism of pyrogallol autoxidation and determination of superoxide dismutase enzyme activityBioelectrochemistry and Bioenergetics, 1998
- Physiological Parameter Values for Physiologically Based Pharmacokinetic ModelsToxicology and Industrial Health, 1997